Brain Blood Flow Deficits Associated With Persistent Long COVID Fatigue
Researchers using specialized brain imaging found that people with long COVID and persistent fatigue exhibited reduced blood flow in their brains compared to healthy control subjects. Study participants with long COVID demonstrated greater fatigue before and after a 20-minute attention task and showed measurable differences in cerebral blood flow that correlated with their symptom severity. These findings provide biological evidence supporting a neurological basis for the exhaustion experienced by many long COVID patients, contributing to growing scientific understanding of the condition's mechanisms.
The research team employed arterial spin labeling, an advanced imaging technique that tracks blood movement through the brain without requiring contrast injections. By monitoring water molecules naturally present in blood, scientists could measure how efficiently oxygen and nutrients reach different neural regions. The study assessed 22 long COVID patients against 19 healthy controls matched by age and sex, documenting both subjective fatigue ratings and objective performance metrics during a sustained attention task.
Beyond the overall reduction in cerebral blood flow, the imaging revealed particularly significant decreases in brain regions responsible for attention, sensory processing, and cognitive control. Importantly, participants with long COVID showed slower reaction times throughout the task, and these slower responses correlated with the measured blood flow deficits, suggesting a biological connection between circulatory changes and cognitive difficulties.
These findings could have meaningful implications for long COVID patients struggling with disabling fatigue that affects their employment and daily functioning. If cerebral blood flow deficits are confirmed as a key mechanism in larger studies, it may eventually guide development of targeted treatments or rehabilitation strategies. The research could also help validate patients' experiences by providing measurable neurological evidence, potentially influencing how healthcare systems approach long COVID management and disability recognition. However, researchers emphasize that much larger studies are needed before drawing definitive conclusions about causation or clinical applications.